103 related articles for article (PubMed ID: 23660325)
1. [Risk factors of predicting residual disease in women with stage I a1 squamous cervical carcinoma after conization].
Zhu XE; Feng Y; Fu YF; Cheng XD; Chen XD; Xie X; Lü WG
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):534-6. PubMed ID: 23660325
[TBL] [Abstract][Full Text] [Related]
2. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
3. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
4. Is conization once following by simple hysterectomy sufficient for all clinical stage IA1 cervical squamous cell carcinoma?
Chen JR; Chiu ML; Wang TY; Chen TC; Wang KG; Su TH; Chang CL; Yang YC; Wang KL
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):385-8. PubMed ID: 24075378
[TBL] [Abstract][Full Text] [Related]
5. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
Takeda N; Suzuki T; Suzuki M; Matsuura M; Tanaka R; Fujii M; Ito E; Saito T
Arch Gynecol Obstet; 2012 Feb; 285(2):453-7. PubMed ID: 21681515
[TBL] [Abstract][Full Text] [Related]
7. The risk of residual neoplasia in women with microinvasive squamous cervical carcinoma and positive cone margins.
Phongnarisorn C; Srisomboon J; Khunamornpong S; Siriaungkul S; Suprasert P; Charoenkwan K; Cheewakriangkrai C; Siriaree S; Pantasri T
Int J Gynecol Cancer; 2006; 16(2):655-9. PubMed ID: 16681742
[TBL] [Abstract][Full Text] [Related]
8. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of microinvasive squamous cell carcinoma of the cervix stage IA1: Defining conization height to an optimal oncological outcome.
Hartman CA; Bragança JF; Gurgel MSC; Zeferino LC; Andrade LALA; Teixeira JC
PLoS One; 2021; 16(7):e0253998. PubMed ID: 34283862
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
12. [Predictors of residual lesion in cervix after conization in patients with cervical intraepithelial neoplasia and microinvasive cervical cancer].
Tan XJ; Wu M; Lang JH; Ma SQ; Shen K; Yang J
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):17-20. PubMed ID: 19489237
[TBL] [Abstract][Full Text] [Related]
13. Is there any predictor for residual disease after cervical conization with positive surgical margins for HSIL or microinvasive cervical cancer?
Tasci T; Turan T; Ureyen I; Karalok A; Kalyoncu R; Boran N; Tulunay G
J Low Genit Tract Dis; 2015 Apr; 19(2):115-8. PubMed ID: 25259663
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of cold knife conization as conservative management in patients with microinvasive cervical squamous cell cancer (stage IA1).
He Y; Wu YM; Zhao Q; Wang T; Wang Y; Kong WM; Song F; Duan W; Zhu L; Zhang WY
Int J Gynecol Cancer; 2014 Sep; 24(7):1306-11. PubMed ID: 24987910
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for residual disease in hysterectomy specimens after conization in early-stage cervical cancer.
Wong AS; Li WH; Cheung TH
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():21-6. PubMed ID: 26894378
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of cervical conization as a definitive treatment for borderline lesions of the uterine cervix].
Matsuyama T; Tsukamoto N; Kashimura M; Iwasaka T; Saito T; Uchino H; Nakano H; Matsukuma K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2063-71. PubMed ID: 6512325
[TBL] [Abstract][Full Text] [Related]
18. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
[TBL] [Abstract][Full Text] [Related]
19. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix.
Morris M; Mitchell MF; Silva EG; Copeland LJ; Gershenson DM
Gynecol Oncol; 1993 Nov; 51(2):193-6. PubMed ID: 8276293
[TBL] [Abstract][Full Text] [Related]
20. Age and prevalence of cervical carcinoma in subsequent hysterectomy following a conization procedure.
Wun TH; Chiu WW; Wang CB; Tseng CC; Chen CH; Lin YH; Lee CY; Sun YL; Tseng CJ
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):254-7. PubMed ID: 19797015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
